Severance Hospital
Seoul, South Korea
NCT Number: NCT01025245
The purpose of this study is to study the effect of intraoperative magnesium on remifentanil-induced postoperative hyperalgesia after thyroidectomy
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Phase 4
Seoul, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients undergoing thyroidectomy will be randomly assigned to one of three groups. Remifentanil will be infused intraoperatively at 0.05 ㎍/㎏/min (group Ⅰ) or 0.2 ㎍/㎏/min (group Ⅱ & Ⅲ). Patients in group Ⅲ will be received 30 ㎎/㎏ MgSO4 at the induction of general anesthesia followed by a maintenance infusion of 10 ㎎/㎏/hr intraoperatively until skin closure.
Time frame: postoperative 48 hrs
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07625475
Central Nervous System Sensitization, Hyperalgesia
Guelph, Ontario, Canada
View Trial DetailsNCT00825422
Hyperalgesia, Nervous System Diseases
Bordeaux, France
View Trial DetailsNCT04902547
Agnosia, Chronic Pain
Winnipeg, Manitoba, Canada
View Trial DetailsNCT01594047
Hyperalgesia, Nervous System Diseases
Milan, Italy
View Trial Details